secwatch / observer
8-K filed October 10, 2024, 7:59 PM ET ticker BIAF CIK 0001712762
leadership confidence high sentiment neutral materiality 0.65

bioAffinity appoints J. Michael Edwards as CFO; $300k salary, $50k bonus, 100k RSUs

bioAffinity Technologies, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

J. Michael Edwards

Chief Financial Officer
BIAF · bioAffinity Technologies, Inc.
Effective
2024-11-05
Filed
October 10, 2024, 7:59 PM ET
On October 4, 2024, the Board of Directors (the “Board”) of bioAffinity technologies, Inc. (the “Company”) appointed J. Michael Edwards, who has served as the Company’s Interim Chief Financial Officer, as a consultant, since September 2024, to serve as Chief Financial Officer of the Company, effective November 5, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

J. Michael Edwards was appointed as Chief Financial Officer at bioAffinity Technologies, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On October 4, 2024, the Board of Directors (the “Board”) of bioAffinity technologies, Inc. (the “Company”) appointed J. Michael Edwards, who has served as the Company’s Interim Chief Financial Officer, as a consultant, since September 2024, to serve as Chief Financial Officer of the Company, effective November 5, 2024.
View on SEC.gov

bioAffinity Technologies, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-040679
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.